Loss of Ag85A disrupts plasma membrane domains and promotes free mycolic acid accumulation in mycobacteria
Authors:
- Takehiro KadoTKTakehiro Kado
- Jake JordanJJJake Jordan
- Joel S. FreundlichJFJoel S. Freundlich
- M. Sloan SiegristMSM. Sloan Siegrist
- Yasu S. MoritaYMYasu S. Morita
Preprint
Abstract
Summary: The mycomembrane of mycobacteria, composed primarily of long-chain mycolic acids, is critical for cell survival, structural integrity, and resistance to environmental stress, yet its underlying synthesis mechanisms remain incompletely understood. This study investigates the role of Ag85A, a key enzyme in mycomembrane synthesis, in regulating plasma membrane domains and cell envelope organization in Mycobacterium smegmatis . Using Δ Ag85A deletion mutants, we combined microscopy, biochemical assays, thin-layer chromatography, and lipid analysis to evaluate changes in membrane structure, chemical accumulation, and lipid composition. Ag85A deletion leads to altered plasma membrane domain organization, increased chemical accumulation, changes in cell envelope lipid composition. Unexpectedly, lipid analysis revealed accumulation—not depletion—of mycolic acids in the mutant, suggesting that increased permeability is not directly due to mycolic acid loss. These findings highlight a novel link between mycomembrane composition and plasma membrane domain stability. Our study not only advances understanding of mycobacterial cell envelope architecture but also identifies potential targets for enhancing drug penetration in resistant mycobacterial infections. Significance: The unique cell envelope of mycobacteria is central to survival, enabling it to resist immune defenses and antibiotic treatment. In this study, we reveal a novel function of Ag85A, a synthase of outmost layer of mycobacteria beyond its known role in mycolyltransferase activity: it is essential for the formation of plasma membrane domains that orchestrate cell envelope synthesis. By structuring plasma membrane domains, Ag85A contributes directly to the resilience of the cell envelope, reinforcing mycobacterial survival mechanisms under hostile conditions. Our findings provide a pivotal insight into mycobacterial cell biology, with broad implications for therapeutic development. Disrupting Ag85A-dependent membrane domain formation could weaken the protective cell envelope, offering a promising approach to enhance current treatments.Keywords
This publication has 55 references indexed in Scilit:
- The Mycomembrane Differentially and Heterogeneously Restricts Antibiotic PermeationACS Infectious Diseases, 2025
- Fluorogenic Probes of the Mycobacterial Membrane as Reporters of Antibiotic ActionJournal of the American Chemical Society, 2024
- Compartmentalization of galactan biosynthesis in mycobacteriaJournal of Biological Chemistry, 2024
- TREM2 is a receptor for non-glycosylated mycolic acids of mycobacteria that limits anti-mycobacterial macrophage activationNature Communications, 2021
- Synthesis and recycling of the mycobacterial cell envelopeCurrent Opinion in Microbiology, 2021
- Several Routes to the Same Destination: Inhibition of Phagosome-Lysosome Fusion by Mycobacterium tuberculosisThe American Journal of the Medical Sciences, 2019
- A Screen for Protein–Protein Interactions in Live Mycobacteria Reveals a Functional Link between the Virulence-Associated Lipid Transporter LprG and the Mycolyltransferase Antigen 85AACS Infectious Diseases, 2017
- Electroporation of Mycobacteria2015
- A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosisNature, 2000
- The genetics and biochemistry of isoniazid resistance inMicrobes and Infection, 2000